Literature DB >> 2039486

1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production.

C G Larsen1, M Kristensen, K Paludan, B Deleuran, M K Thomsen, C Zachariae, K Kragballe, K Matsushima, K Thestrup-Pedersen.   

Abstract

Interleukin 8 (IL-8) is a potent leukocyte chemotactic and activating cytokine produced by keratinocytes, fibroblasts, peripheral blood monocytes (PBMC) and endothelial cells. IL-8 is believed to play an important role in the development of inflammation and is thus an obvious target for therapeutical modulation. We studied the possible effect of an endogenous immune modulator 1,25(OH)2-cholecalciferol (1,25(OH)2-D3) on the IL-1-induced IL-8-production by several types of cells. 1,25(OH)2-D3 inhibited the IL-1-alpha induced IL-8 production and mRNA expression in keratinocytes, fibroblasts and PBMC, but not in endothelial cells. Optimal vitamin concentrations varied between 10(-10) and 10(-11) M. These results suggest a potential role of this hormone in the regulation of chemotactic cytokine production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039486     DOI: 10.1016/0006-291x(91)90384-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice.

Authors:  H Sato; I Sugimoto; T Matsunaga; M Tsuchimoto; T Ohta; H Uno; M Kiyoki
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

Review 2.  Vitamin D3 modulates the innate immune response through regulation of the hCAP-18/LL-37 gene expression and cytokine production.

Authors:  Daniel Svensson; Daniel Nebel; Bengt-Olof Nilsson
Journal:  Inflamm Res       Date:  2015-10-03       Impact factor: 4.575

Review 3.  Vitamin D3 and skin diseases.

Authors:  K Kragballe
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 4.  Peptides and cytokines.

Authors:  J M Schröder
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.

Authors:  K Oishi; F Sonoda; S Kobayashi; A Iwagaki; T Nagatake; K Matsushima; K Matsumoto
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells.

Authors:  Theodoros Eleftheriadis; Georgia Antoniadi; Vassilios Liakopoulos; Charalambos Kartsios; Ioannis Stefanidis; Grammati Galaktidou
Journal:  Int Urol Nephrol       Date:  2009-03-04       Impact factor: 2.370

7.  Synergy between vitamin D(3) and Toll-like receptor agonists regulates human dendritic cell response during maturation.

Authors:  Anne Brosbøl-Ravnborg; Bettina Bundgaard; Per Höllsberg
Journal:  Clin Dev Immunol       Date:  2013-04-07

Review 8.  Vitamin D in inflammatory diseases.

Authors:  Thea K Wöbke; Bernd L Sorg; Dieter Steinhilber
Journal:  Front Physiol       Date:  2014-07-02       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.